Latest Views & News
I'm Banging on About this Cancer-Zapper, Again - But It's Still on Course for Share Success.
By Malcolm Stacey | Thursday 12 May 2016
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Hello Share Crafters. In the past I’ve probably written too many pieces on a medical share which I like. During that period, I’ve seen the shares rise from 2p to 17p. Sadly, the share price has reversed back to 6.5p. And the worst of it is I bought a shedload more shares when they were around 10p. I refer, of course, to that darling of the bulletin boards Advanced Oncotherapy (AVO). I haven’t featured the company for some time now and it’s probably worth an update.
Filed under:
- Advanced Oncotherapy
- avo
- cancer
- proton
- chief executive
- bulletin board
- punter's return
- Michael Sinclair
- shares
- share price
Market News
Advance Energy (#ADV) – Buffalo licence lapses, becomes a cash shell
27 May 2022, 07:54
#DWF – appointment of Berenberg as joint corporate broker
27 May 2022, 07:48
Vistry (#VTY) – commencement of up to £35m share buyback programme
27 May 2022, 07:37
#RUA Life Sciences – FY increased loss, cash down to below £3m
27 May 2022, 07:28
